The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 8th 2025
The fixed-dose combination yielded a 49% greater reduction in low density lipoprotein cholesterol (LDL-C) compared with placebo.
Efficacy and Safety of FOLFIRI for Previously Treated Advanced Pancreatic Cancer
January 29th 2021The treatment of 5-fluorouracil with levofolinate and irinotecan was found to be well-tolerated and effective as a second-line treatment for patients with gemcitabine-refractory advanced pancreatic cancer.
Read More
Walgreens Provides an Update on COVID-19 Vaccination Administration Across the Country
January 28th 2021In a progress update on COVID-19 vaccine administration and testing in Walgreens pharmacies, speakers discussed the rollout and implementation of the COVID-19 vaccination process in LTC facilities.
Read More
Research Shows Women Still Face Disparities in Global Burden of Stroke
January 27th 2021Two of the studies specifically address the concerns about the lack of women in stroke clinical trials, causing a dearth in information to ensure appropriate stroke treatment for women, which has been an issue for scientists.
Read More
Lack of Sleep, Stress Can Cause Symptoms Resembling Concussion
January 27th 2021Because there are multiple sources for concussion-like symptoms, student-athletes’ post-concussion care should zero in on which symptoms are specifically caused by the injury and which may be caused by other issues.
Read More
SCOTUS Ruling May Help Independent Community Pharmacies Rebuild
January 27th 2021Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on how the recent SCOTUS ruling on Rutledge v. PCMA may help independent community pharmacies rebuild what may have been lost due to low reimbursement rates.
Watch
Data Demonstrate the Clinical Benefit of Onvansertib in KRAS-Mutated mCRC
January 27th 2021Data from a phase 1b/2 study investigating onvansertib as a treatment of KRAS-mutated mCRC demonstrated that 42% of patients achieved a PR and 67% demonstrated a durable response ranging from 6.1 months to 13.7 months.
Read More
Older Adults’ Lack of Online Medical Accounts Could Affect COVID-19 Vaccinations
January 26th 2021In addition to communicating about COVID-19 vaccine eligibility, uses for online portals include requesting prescription refills, seeking advice on health concerns, and scheduling appointments.
Read More
Researchers Conduct First-of-Its-Kind Review of National Data, HPV Vaccination Rates
January 26th 2021HPV is the most common sexually transmitted infection, and if a high-risk infection does not go away, it can lead to the development of a variety of cancers, including 91% of all cervical cancers, 70% of oropharyngeal cancers, and cancers of the vulva, vagina, and penis and anus.
Read More
NCPA Urges Biden Administration to Consider Independent Pharmacies as Part of COVID-19 Strategy
January 26th 2021Following the release of the Biden administration’s COVID-19 response strategy, NCPA issued its support and urged the government to also consider engaging independent pharmacies in its implementation.
Read More
Recent SCOTUS Ruling Provides Hope for Change in Reimbursement Policies for Community Pharmacy
January 25th 2021Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on how the recent unanimous SCOTUS ruling on Rutledge v. PCMA will impact independent pharmacies across the country.
Watch
Study: Personalized Brain Stimulation Alleviates Severe Depression Symptoms
January 25th 2021The approach is being developed specifically as a potential treatment for the significant fraction of people with debilitating depression who do not respond to existing therapies and are at high risk of suicide.
Read More
FDA Approves Rilpivirine, Cabotegravir as the First Long-Acting Regimen for HIV Treatment
January 23rd 2021The FDA has approved cabenuva, which consists of rilpivirine and cabotegravir, for treating HIV-1 infection in adults. This therapy is the first once-monthly, long-acting injectable to be approved for the treatment of HIV.
Read More
Severe Menopause Symptoms Linked With Premature Ovarian Insufficiency
January 22nd 2021Health care providers should be more cognizant of psychological complications and sexual dysfunction risks in women with premature ovarian insufficiency and should work with patients to identify options for relief.
Read More